ACTRN12605000782639
Completed
Phase 1
A phase I study to assess the pharmacokinetics of a single dose of a slow-release solid injection of EPT1647 in healthy male volunteers
Epitan Limited0 sites6 target enrollmentDecember 7, 2005
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- /A
- Sponsor
- Epitan Limited
- Enrollment
- 6
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\* Healthy caucasian \* No history of Melanoma includinjg in a first degree relative\* No significant medical history or disorder\* Take precautions to prevent pregnancy during and upto 3 months after study.\* No history of drug or alcohol abuse.
Exclusion Criteria
- •No exclusion criteria
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
A Phase 1 Study of Olorofim in Healthy Japanese and Caucasian ParticipantsHealthy adult participantsJPRN-jRCT2031230016agata Tsutae24
Recruiting
Phase 1
MYCATJapanese Patients with Pulmonary MABC DiseaseJPRN-jRCT2031220211Ho Namkoong10
Recruiting
Not Applicable
A phase I study to evaluate the pharmacokinetic interactions and safety between Amlodipine/Valsartan combination tablet and Rosuvastatin in healthy adult volunteersDiseases of the circulatory systemKCT0001660Kyung Dong Pharmaceutical57
Withdrawn
Not Applicable
A Phase 1 Pharmacokinetic-Pharmacodynamic Study of Avelumab (MSB00100718C) in Patients with Previously Treated Advanced Stage Classical Hodgkin*s LymphomaHodgkin's Lymphomalymph node cancer10025319NL-OMON43446Pfizer15
Completed
Not Applicable
A Phase 1 Study to Compare the Pharmacokinetics of CAL-101 Capsules to Tablets in Healthy Male Subjects.Blooddiseaseleukemia/lymophoma10047954NL-OMON35094Calistoga Pharmaceuticals Inc.15